尤卡坦迷你猪对心房的模型:临床相关性
Pouria Mostafizi1, Eli Lefkowitz1,2, Jacob Ref1,2
1Sarver Heart Center, University of Arizona, Tucson, Arizona, United States of America.
PloS one
|February 4, 2026
概括
研究人员在尤卡坦州 miniswine.wine开发了一种针对持续性心房动 (AFib) 的大型动物模型. 这种新模型显示活动减少和纤维化增加,有助于研究新型AFib疗法.
科学领域:
- 心血管研究研究心血管研究
- 动物模型 动物模型
- 节律失常研究 节律失常研究
背景情况:
- 持续性心房动 (AFib) 是美国普遍存在的慢性心律失常症,与中风和心力衰竭等严重并发症有关.
- 目前对AFib的治疗方法,包括导管切除和抗心律不良药,对于许多患者来说通常是无效的.
- 需要先进的研究模型来探索持续性AFib的创新治疗策略.
研究的目的:
- 建立一个持久性心房动 (AFib) 的大型动物模型,使用Yucatan miniswine.
- 为了促进对持久性AFib的新型治疗方法的调查.
- 评估猪诱导持续性AFib对生理和生活质量的影响.
主要方法:
- 尤卡坦迷你猪因其类似人类的生理学和适合长期研究的尺寸而被选中.
- 动物经过手术植入心房节拍线,发电机和可插入的心脏监视器.
- 快速心房节奏被用来诱导持续的AFib,在诱导后分析了活动水平和组织病理学.
主要成果:
- 持续性AFib在约80天内成功诱导了6个尤卡坦小猪中的3个.
- 诱导持续性AFib导致动物活动水平下降,表明生活质量下降.
- 组织病理学检查显示,受影响的动物有显著的心房纤维化和心肌细胞损失.
结论:
- 开发的尤卡坦迷你猪模型有效地复制了持续性心房的关键特征,包括生理变化和生活质量降低.
- 这种模型为临床前研究提供了一个强大的平台,用于针对持续性AFib的新疗法.
- 克服手术挑战对于建立AFib研究的可重复模型至关重要.
相关概念视频
Amyloid Fibrils
12.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.0K
Amyloid Fibrils
6.4K
6.4K
Clinically Relevant Drug Product Specifications: Methods of Establishment
222
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
222
Fibril-associated Collagen
3.4K
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.4K
Nursing Clinical Information System
1.3K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.3K
Clinical Trials
10.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.8K


